SCHEMBL14857328

SCHEMBL14857328

CCCCCCCCCCCCCCOC1=CC(=O)C(C(=O)OCC(=O)N2CCN(C3CCCCC3)CC2)O1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ THRB P10828 1/20 0.40
▸ ALDH1A1 P00352 4/20 0.38
▸ TSHR P16473 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ PDE3B Q13370 1/20 0.37
▸ PDE3A Q14432 1/20 0.37
▸ POLB P06746 1/20 0.36
▸ ORAI1 Q96D31 1/20 0.36
▸ TP53 P04637 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ ACHE P22303 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14857329 0.84 POLB (0.51) KDM4ESMN1; SMN2THRBALDH1A1POLB
SCHEMBL14857112 0.79 L3MBTL1 (0.45) ALDH1A1KMT2A
SCHEMBL14857312 0.78 KMT2A (0.40) THRBALDH1A1TSHRKMT2APOLB
SCHEMBL992344 0.75 KMT2A (0.47) KDM4ESMN1; SMN2THRBALDH1A1TSHR
SCHEMBL14857296 0.72 PPARG (0.39) ALDH1A1TSHRTP53MAPT
SCHEMBL14857330 0.71 THRB (0.48) KDM4ESMN1; SMN2THRBALDH1A1TSHR
SCHEMBL14857326 0.71 THRB (0.48) KDM4ESMN1; SMN2THRBALDH1A1KMT2A
SCHEMBL14857331 0.70 TSHR (0.36) ALDH1A1TSHRTP53NPSR1
SCHEMBL14857301 0.70 TSHR (0.36) ALDH1A1TSHRCYP2D6
SCHEMBL14857335 0.69 ALDH1A1 (0.36) SMN1; SMN2THRBALDH1A1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2451796-B1 TOFA ANALOGS USEFUL IN TREATING DERMATOLOGICAL DISORDERS OR CONDITIONS DERMIRA CANADA INC (US) 2013-04-17 — — EP claimed
Send feedback